DOCSLIB.ORG

Review Multiplicity of Mammalian Reductases for Xenobiotic Carbonyl Compounds

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Review Multiplicity of Mammalian Reductases for Xenobiotic Carbonyl Compounds Drug Metab. Pharmacokinet. 21 (1): 1–18 (2006). Review Multiplicity of Mammalian Reductases for Xenobiotic Carbonyl Compounds Toshiyuki MATSUNAGA, Shinichi SHINTANI and Akira HARA* Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu, Japan Full text of this paper is available at http://www.jstage.jst.go.jp/browse/dmpk Summary: A variety of carbonyl compounds are present in foods, environmental pollutants, and drugs. These xenobiotic carbonyl compounds are metabolized into the corresponding alcohols by many mammalian NAD(P)H-dependent reductases, which belong to the short-chain dehydrogenaseWreductase (SDR) and aldo-keto reductase superfamilies. Recent genomic analysis, cDNA isolation and characteriza- tion of the recombinant enzymes suggested that, in humans, the six members of each of the two superfamilies, i.e., total of 12 enzymes, are involved in the reductive metabolism of xenobiotic carbonyl compounds. They comprise three types of carbonyl reductase, dehydrogenaseWreductase (SDR family) member 4, 11b-hydroxysteroid dehydrogenase type 1, L-xylulose reductase, two types of a‰atoxin B1 aldehyde reductase, 20a-hydroxysteroid dehydrogenase, and three types of 3a-hydroxysteroid dehydrogenase. Accumulating data on the human enzymes provide new insights into their roles in cellular and molecular reactions including xenobiotic metabolism. On the other hand, mice and rats lack the gene for a protein corresponding to human 3a-hydroxysteroid dehydrogenase type 3, but instead possess additional ˆve or six genes encoding proteins that are structurally related to human hydroxy- steroid dehydrogenases. Characterization of the additional enzymes suggested their involvement in species-speciˆc biological events and species diŠerences in the metabolism of xenobiotic carbonyl compounds. Key words: Carbonyl reduction; short-chain dehydrogenaseWreductase superfamily; aldo-keto reductase superfamily; carbonyl reductase; hydroxysteroid dehydrogenase; species diŠerence alcohols by NADPH-dependent reductases with broad Introduction substrate speciˆcity. Some NADPH-dependent reduc- Aldehydes, ketones and quinones are present in a tases reduce quinones through two-electron transfer to diverse range of natural and synthetic compounds to the corresponding hydroqinones, which is also mediated which living organisms are exposed. In addition, car- by NA(D)PH:quinone reductase. This group of reduc- bonyl compounds are formed through biological tases with broad substrate speciˆcity for xenobiotic transformation of endogenous components and carbonyl compounds was originally called `aldo-keto xenobiotics that are ingested. Aldehydes are chemically reductases'1) andWor `carbonyl reductases'.2) Subse- reactive and interact with the nucleophilic centers of quently, according to the accumulated knowledge on nucleic acids and proteins. a-Dicarbonyl compounds, the functions and structures of the reductases, most such as methyl glyoxal and diacetyl, are more reactive. carbonyl-reducing enzymes have been grouped into two Ketones are less reactive, and many drugs contain keto distinct protein families, the short-chain dehydrogenase group(s). Quinones have a toxic eŠect, i.e., quinone- (SDR)3) and aldo-keto reductase (AKR)4) superfamilies. induced oxidative stress, when they are reduced through There had been three excellent reviews on the single-electron transfer to the corresponding semiqui- carbonyl-reducing enzymes by 2000.5–7) Over the recent nones. Organisms have evolved several enzyme systems ˆve years, several new enzymes that may reduce for detoxifying reactive carbonyl compounds. Such well xenobiotic carbonyl compounds have been found on established pathways include the oxidation of aldehydes genomic analysis, and thus the enzyme names have been to the corresponding carboxylic acids by aldehyde changed. For example, well-known carbonyl reductase dehydrogenases and aldehyde oxidases, and the reduc- (CBR), a member of the SDR superfamily, is now tion of aldehydes and ketones into the corresponding named CBR1 according to the Human Gene Nomencla- Received; September 30, 2005, Accepted; October 24, 2005 *To whom correspondence should be addressed:AkiraHARA, Laboratory of Biochemistry, Gifu Pharmaceutical University, Mitahora-higashi, Gifu, Gifu 502-8585, Japan. Tel. & Fax. ＋81-58-237-8586, E-mail: hara＠gifu-pu.ac.jp 1 2 Toshiyuki MATSUNAGA et al. Table 1. Human enzymes involved in the reduction of xenobiotic carbonyl compounds. Gene name Subcellular Accession Enzymes (location) Other names Endogenous substrates localization numbera) SDR family CBR1 CBR1 Carbonyl reductase, PG 9-ketoreductase PG, isatin, (21q22.13) ketosteroids Cytoplasm P16152 CBR3 CBR3 Unknown Cytoplasm O75828 (21q22.2) 11bHSD 1 HSD11B1 Corticosteroid 11b-dehydrogenase isozyme 1 11-Ketoglucocorticoids Microsomes P28845 (1q32-q41) DHRS4 Dhrs4 Peroxisomal short-chain alcohol dehydrogenase, Retinal Peroxisomes Q9BTZ2 (14q11.2) NADPH-dependent retinol dehydrogenaseWreductase (NDRD) L-Xylulose DXCR DicarbonylWL-xylulose reductase, diacetyl L-Xylulose, diacetyl Cytoplasm Q7Z4W1 reductase (17q25.3) reductase AKR family AKR7A2 AKR7A2 A‰atoxin B1 aldehyde reductase member 2, Succinic semialdehyde Golgi O43488 (1p35.1-p36.23) AFAR2 AKR7A3 AKR7A3 A‰atoxin B1 aldehyde reductase member 3, Unknown Cytoplasm O95154 (1p35.1-p36.23) AFAR1 AKR1C1 AKR1C1 20a-HSD, 3(20)a-HSD, DD1 3- and 20-ketosteroids Cytoplasm Q04828 (10 q15-q14) AKR1C2 AKR1C2 3a-HSD type 3, DD2, bile acid-binding protein 3-Ketosteroids Cytoplasm P52895 (10 q15-q14) AKR1C3 AKR1C3 3a-HSD type 2, 17b-HSD type 5, PGF synthase, 3-, 17- and 20-keto- Cytoplasm P42330 (10 q15-q14) DDX steroids, PGD2 AKR1C4 AKR1C4 3a-HSD type 1, DD4, chlordecone reductase 3-ketosteroids Cytoplasm P17516 (10 q15-q14) a)The structural and functional information is available under the accession numbers of UniprotKBWSwiss-Prot (http:WWkr.expasy.orgWsprotW). ture Committee (HGNC), because of the occurrence of reductase exhibit broad substrate speciˆcities for four types of CBR. Several mammalian enzymes that xenobiotic carbonyl compounds (Tables 1 and 2). CBRs were regarded as CBRs in the previous reviews are now are classiˆed into four types, CBR1, CBR2, CBR3 and classiˆed into CBR1-CBR3 or have been identiˆed as CBR4 (Table 3). members of the AKR superfamily. The enzymes that 1. Carbonyl reductases (CBRs, EC 1.1.1.181) belong to the AKR superfamily have also been named CBR1: The cDNA for the human enzyme was ˆrst according to the nomenclature for this superfamily. In cloned by Wermuth et al.,8) who also characterized its addition, novel physiological roles of several enzymes properties using the enzyme puriˆed from the brain, and have been reported. Therefore, we have reviewed the proposed its identity with xenobiotic ketone reductase literature on mammalian carbonyl-reducing enzymes and prostaglandin (PG) 9-ketoreductase.9) The enzyme using the new nomenclature in order to clarify their is ubiquitously distributed in human tissues.10) The gene relationship with the previously known enzymes. is mapped to chromosome 21q22.12, very close to the superoxide dismutase 1 locus at position 21q22.11.11) Carbonyl-reducing Enzymes in the SDR Superfamily The mRNA expression in MCF-7 cells is induced 3- or The SDR superfamily includes about 3,000 primary 4-fold in 24 hours by 2,(3)-t-butyl-4-hydroxyanisole, structures of functionally heterogeneous proteins, and b-naphtho‰avone, or Sudan 1.12) Human CBR1 is a becomes one of the largest protein families to date.3) 30 kDa-monomer comprising 277 amino acids, and The sequence identity of the members of this family is belongs to the SDR family. Recently, Tanaka et al.13) low, but the three-dimensional structures of many solved the crystal structure of the enzyme-NADP＋- members exhibit highly similar aWb folding patterns inhibitor complex, which has provided important in- with a central b-sheet, typical of the Rossmann-fold that sights as to the substrate binding site and the design of participates in cofactor binding. The catalytic tetrad of potent inhibitors of the enzyme, although its tertiary Asn-Ser-Tyr-Lys is conserved in the members of this structure is highly similar to that of porcine CBR1.14) superfamiy. Among the members, CBRs, 11b-hydro- Human CBR1 catalyzes the NADPH-dependent xysteroid dehydrogenase (HSD) type 1, dehydrogenaseW reduction of various carbonyl compounds, the best sub- reductase (SDR family) member 4 and L-xylulose strates being p-ando-quinones derived from polycyclic Mammalian Carbonyl-Reducing Enzymes 3 Table 2. Typical xenobiotic substrates of human reductases. Enzyme Drugs Others CBR1 Daunorubicin, doxorubicin, haloperidol, Quinones, aromatic aldehydes, aromatic ketones, NNK bromperidol, metyrapone, loxoprofen, wortmannin, dolasetron CBR3 Menadione 11bHSD 1 Ketoprofen, metyrapone, insecticidal metyrapone NNK, menadione, aromatic aldehydes and ketones, 7-ketocholesterol analogues, oracin DHRS4 Dicarbonyl compounds with aromatic rings, alkyl phenyl ketones, some aromatic aldehydes and ketones L-Xylulose Dicarbonyl compounds, some aromatic aldehydes and ketones reductase AKR7A2 Daunorubicin, ethacrynic acid A‰atoxin B1 dialdehyde, dicarbonyl compounds, aromatic aldehydes AKR7A3 A‰atoxin B1 dialdehyde, 9,10-phenanthrenequinone,4-nitrobenzaldehyde AKR1C1 Dolasetron, naloxone, naltrexone, oxycodone, oracin, Aromatic aldehydes and ketones, quinones, dicarbonyl compounds, befunolol, ketotifen, 10-oxonortriptyline, haloperidol, NNK, trans-dihydrodiols of aromatic hydrocarbons, alicyclic alcohols loxoprofen,
Load more

Recommended publications
  • Modern-Reduction-Methods.Pdf
    Modern Reduction Methods Edited by Pher G. Andersson and Ian J. Munslow Related Titles Yamamoto, H., Ishihara, K. (eds.) Torii, S. Acid Catalysis in Modern Electroorganic Reduction Organic Synthesis Synthesis 2008 2006 ISBN: 978-3-527-31724-0 ISBN: 978-3-527-31539-0 Roberts, S. M. de Meijere, A., Diederich, F. (eds.) Catalysts for Fine Chemical Metal-Catalyzed Cross- Synthesis V 5 – Regio and Coupling Reactions Stereo-Controlled Oxidations 2004 and Reductions ISBN: 978-3-527-30518-6 2007 Online Book Wiley Interscience Bäckvall, J.-E. (ed.) ISBN: 978-0-470-09024-4 Modern Oxidation Methods 2004 de Vries, J. G., Elsevier, C. J. (eds.) ISBN: 978-3-527-30642-8 The Handbook of Homogeneous Hydrogenation 2007 ISBN: 978-3-527-31161-3 Modern Reduction Methods Edited by Pher G. Andersson and Ian J. Munslow The Editors All books published by Wiley-VCH are carefully produced. Nevertheless, authors, editors, and Prof. Dr. Pher G. Andersson publisher do not warrant the information Uppsala University contained in these books, including this book, to Department of Organic Chemistry be free of errors. Readers are advised to keep in Husargatan 3 mind that statements, data, illustrations, 751 23 Uppsala procedural details or other items may Sweden inadvertently be inaccurate. Dr. Ian J. Munslow Library of Congress Card No.: Uppsala University applied for Department of Biochemistry and Organic Chemistry Husargatan 3 British Library Cataloguing-in-Publication Data 751 23 Uppsala A catalogue record for this book is available from Sweden the British Library. Bibliographic information published by the Deutsche Nationalbibliothek Die Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografi e; detailed bibliographic data are available on the Internet at <http://dnb.d-nb.de>.
    [Show full text]
  • Comparative Modeling and Functional Characterization of Two Enzymes of the Cyclooxygenase Pathway in Drosophila Melanogaster
    City University of New York (CUNY) CUNY Academic Works All Dissertations, Theses, and Capstone Projects Dissertations, Theses, and Capstone Projects 2-2014 Comparative Modeling and Functional Characterization of Two Enzymes of the Cyclooxygenase Pathway in Drosophila melanogaster Yan Qi Graduate Center, City University of New York How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/gc_etds/94 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] Comparative Modeling and Functional Characterization of Two Enzymes of the Cyclooxygenase Pathway in Drosophila melanogaster by Yan Qi A dissertation submitted to the Graduate Faculty in Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy, The City University of New York 2014 i © 2014 Yan Qi All Rights Reserved ii This manuscript has been read and accepted for the Graduate Faculty in Biology in satisfaction of the dissertation requirement for the degree of Doctor of Philosophy. _______ ______________________ Date Chair of Examining Committee Dr. Shaneen Singh, Brooklyn College _______ ______________________ Date Executive Officer Dr. Laurel A. Eckhardt ______________________ Dr. Peter Lipke, Brooklyn College ______________________ Dr. Shubha Govind, City College ______________________ Dr. Richard Magliozzo, Brooklyn College ______________________ Dr. Evros Vassiliou, Kean University Supervising Committee The City University of New York iii Abstract Comparative Modeling and Functional Characterization of Two Enzymes of the Cyclooxygenase Pathway in Drosophila melanogaster by Yan Qi Mentor: Shaneen Singh Eicosanoids are biologically active molecules oxygenated from twenty carbon polyunsaturated fatty acids.
    [Show full text]
  • Lanthanide Replacement in Organic Synthesis: Calcium-Mediated Luche-Type Reduction of Α,Β-Functionalised Ketones
    Lanthanide Replacement in Organic Synthesis: Calcium-mediated Luche-type Reduction of α,β-functionalised Ketones A thesis submitted by Nina Viktoria Forkel In partial fulfilment of the requirement for a degree of Doctor of Philosophy Imperial College London Department of Chemistry South Kensington Campus SW7 2AZ London United Kingdom September 2013 Lanthanide Replacement in Organic Synthesis: Calcium-mediated Luche-type Reduction of α,β-functionalised Ketones “Man kann sich die Weite und Möglichkeiten des Lebens gar nicht unerschöpflich genug denken.” (Rainer Maria Rilke) This thesis is dedicated to all my loved ones. Declaration of originality and statement of copyright Declaration of originality I, Nina V. Forkel, certify that the research described within this thesis was carried out in the Department of Chemistry at Imperial College London between October 2009 and September 2012. It was accomplished under the primary supervision of Dr Matthew J. Fuchter, Imperial College London, along with supervision from Dr David A. Henderson, Pfizer Ltd. The entire body of work is that of the author, unless otherwise stated to the contrary, and has not been submitted previously for a degree at this or any other university. Statement of copyright The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes, and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the licence terms of this work.
    [Show full text]
  • Systems and Chemical Biology Approaches to Study Cell Function and Response to Toxins
    Dissertation submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences Presented by MSc. Yingying Jiang born in Shandong, China Oral-examination: Systems and chemical biology approaches to study cell function and response to toxins Referees: Prof. Dr. Rob Russell Prof. Dr. Stefan Wölfl CONTRIBUTIONS The chapter III of this thesis was submitted for publishing under the title “Drug mechanism predominates over toxicity mechanisms in drug induced gene expression” by Yingying Jiang, Tobias C. Fuchs, Kristina Erdeljan, Bojana Lazerevic, Philip Hewitt, Gordana Apic & Robert B. Russell. For chapter III, text phrases, selected tables, figures are based on this submitted manuscript that has been originally written by myself. i ABSTRACT Toxicity is one of the main causes of failure during drug discovery, and of withdrawal once drugs reached the market. Prediction of potential toxicities in the early stage of drug development has thus become of great interest to reduce such costly failures. Since toxicity results from chemical perturbation of biological systems, we combined biological and chemical strategies to help understand and ultimately predict drug toxicities. First, we proposed a systematic strategy to predict and understand the mechanistic interpretation of drug toxicities based on chemical fragments. Fragments frequently found in chemicals with certain toxicities were defined as structural alerts for use in prediction. Some of the predictions were supported with mechanistic interpretation by integrating fragment- chemical, chemical-protein, protein-protein interactions and gene expression data. Next, we systematically deciphered the mechanisms of drug actions and toxicities by analyzing the associations of drugs’ chemical features, biological features and their gene expression profiles from the TG-GATEs database.
    [Show full text]
  • Comprehensive Identification and Characterization of Somatic Copy Number Alterations in Triple‑Negative Breast Cancer
    INTERNATIONAL JOURNAL OF ONCOLOGY 56: 522-530, 2020 Comprehensive identification and characterization of somatic copy number alterations in triple‑negative breast cancer ZAIBING LI1,2*, XIAO ZHANG3*, CHENXIN HOU4, YUQING ZHOU4, JUNLI CHEN1, HAOYANG CAI5, YIFENG YE3, JINPING LIU3 and NING HUANG1 1Department of Pathophysiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041; 2Department of Pathophysiology, School of Basic Medical Science, Southwest Medical University, Luzhou, Sichuan 646000; 3Department of Breast Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 611731; 4West China Medical School, Sichuan University, Chengdu, Sichuan 610041; 5Center of Growth, Metabolism and Aging, Key Laboratory of Bio‑Resources and Eco‑Environment, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, P.R. China Received January 30, 2019; Accepted August 30, 2019 DOI: 10.3892/ijo.2019.4950 Abstract. Triple-negative breast cancer (TNBC) accounts hierarchical clustering of tumors resulted in three main for ~15% of all breast cancer diagnoses each year. Patients subgroups that exhibited distinct CNA profiles, which with TNBC tend to have a higher risk for early relapse and may reveal the heterogeneity of molecular mechanisms in a worse prognosis. TNBC is characterized by extensive TNBC subgroups. These results will extend the molecular somatic copy number alterations (CNAs). However, the DNA understanding of TNBC and will facilitate the discovery of CNA profile of TNBC remains to be extensively investigated. therapeutic and diagnostic target candidates. The present study assessed the genomic profile of CNAs in 201 TNBC samples, aiming to identify recurrent CNAs that Introduction may drive the pathogenesis of TNBC.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Investigation of Copy Number Variations on Chromosome 21 Detected by Comparative Genomic Hybridization
    Li et al. Molecular Cytogenetics (2018) 11:42 https://doi.org/10.1186/s13039-018-0391-3 RESEARCH Open Access Investigation of copy number variations on chromosome 21 detected by comparative genomic hybridization (CGH) microarray in patients with congenital anomalies Wenfu Li, Xianfu Wang and Shibo Li* Abstract Background: The clinical features of Down syndrome vary among individuals, with those most common being congenital heart disease, intellectual disability, developmental abnormity and dysmorphic features. Complex combination of Down syndrome phenotype could be produced by partially copy number variations (CNVs) on chromosome 21 as well. By comparing individual with partial CNVs of chromosome 21 with other patients of known CNVs and clinical phenotypes, we hope to provide a better understanding of the genotype-phenotype correlation of chromosome 21. Methods: A total of 2768 pediatric patients sample collected at the Genetics Laboratory at Oklahoma University Health Science Center were screened using CGH Microarray for CNVs on chromosome 21. Results: We report comprehensive clinical and molecular descriptions of six patients with microduplication and seven patients with microdeletion on the long arm of chromosome 21. Patients with microduplication have varied clinical features including developmental delay, microcephaly, facial dysmorphic features, pulmonary stenosis, autism, preauricular skin tag, eye pterygium, speech delay and pain insensitivity. We found that patients with microdeletion presented with developmental delay, microcephaly, intrauterine fetal demise, epilepsia partialis continua, congenital coronary anomaly and seizures. Conclusion: Three patients from our study combine with four patients in public database suggests an association between 21q21.1 microduplication of CXADR gene and patients with developmental delay. One patient with 21q22.13 microdeletion of DYRK1A shows association with microcephaly and scoliosis.
    [Show full text]
  • Coordinate Regulation of Long Non-Coding Rnas and Protein-Coding Genes in Germ- Free Mice Joseph Dempsey, Angela Zhang and Julia Yue Cui*
    Dempsey et al. BMC Genomics (2018) 19:834 https://doi.org/10.1186/s12864-018-5235-3 RESEARCHARTICLE Open Access Coordinate regulation of long non-coding RNAs and protein-coding genes in germ- free mice Joseph Dempsey, Angela Zhang and Julia Yue Cui* Abstract Background: Long non-coding RNAs (lncRNAs) are increasingly recognized as regulators of tissue-specific cellular functions and have been shown to regulate transcriptional and translational processes, acting as signals, decoys, guides, and scaffolds. It has been suggested that some lncRNAs act in cis to regulate the expression of neighboring protein-coding genes (PCGs) in a mechanism that fine-tunes gene expression. Gut microbiome is increasingly recognized as a regulator of development, inflammation, host metabolic processes, and xenobiotic metabolism. However, there is little known regarding whether the gut microbiome modulates lncRNA gene expression in various host metabolic organs. The goals of this study were to 1) characterize the tissue-specific expression of lncRNAs and 2) identify and annotate lncRNAs differentially regulated in the absence of gut microbiome. Results: Total RNA was isolated from various tissues (liver, duodenum, jejunum, ileum, colon, brown adipose tissue, white adipose tissue, and skeletal muscle) from adult male conventional and germ-free mice (n = 3 per group). RNA-Seq was conducted and reads were mapped to the mouse reference genome (mm10) using HISAT. Transcript abundance and differential expression was determined with Cufflinks using the reference databases NONCODE 2016 for lncRNAs and UCSC mm10 for PCGs. Although the constitutive expression of lncRNAs was ubiquitous within the enterohepatic (liver and intestine) and the peripheral metabolic tissues (fat and muscle) in conventional mice, differential expression of lncRNAs by lack of gut microbiota was highly tissue specific.
    [Show full text]
  • Datasheet: VMA00346 Product Details
    Datasheet: VMA00346 Description: MOUSE ANTI AKR1C2 Specificity: AKR1C2 Format: Purified Product Type: PrecisionAb™ Monoclonal Isotype: IgG2a Quantity: 100 µl Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Product Form Purified IgG - liquid Preparation Mouse monoclonal antibody prepared by affinity chromatography on Protein G Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide (NaN3) Stabilisers Immunogen Recombinant human AKR1C2 External Database Links UniProt: P52895 Related reagents Entrez Gene: 1646 AKR1C2 Related reagents Synonyms DDH2 Specificity Mouse anti Human AKR1C2 antibody recognizes the aldo-keto reductase family 1 member C2, also known as 3-alpha-HSD3, DD-2, DD/BABP, aldo-keto reductase family 1 member C2, Page 1 of 2 chlordecone reductase homolog HAKRD, dihydrodiol dehydrogenase 2, bile acid binding protein, 3-alpha hydroxysteroid dehydrogenase, type III, pseudo-chlordecone reductase, testicular 17,20-desmolase deficiency, trans-1,2-dihydrobenzene-1,2-diol dehydrogenase and type II dihydrodiol dehydrogenase. Encoded by the AKR1C2 gene, aldo-keto reductase family 1 member C2 is a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins.
    [Show full text]
  • Enzyme DHRS7
    Toward the identification of a function of the “orphan” enzyme DHRS7 Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von Selene Araya, aus Lugano, Tessin Basel, 2018 Originaldokument gespeichert auf dem Dokumentenserver der Universität Basel edoc.unibas.ch Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von Prof. Dr. Alex Odermatt (Fakultätsverantwortlicher) und Prof. Dr. Michael Arand (Korreferent) Basel, den 26.6.2018 ________________________ Dekan Prof. Dr. Martin Spiess I. List of Abbreviations 3α/βAdiol 3α/β-Androstanediol (5α-Androstane-3α/β,17β-diol) 3α/βHSD 3α/β-hydroxysteroid dehydrogenase 17β-HSD 17β-Hydroxysteroid Dehydrogenase 17αOHProg 17α-Hydroxyprogesterone 20α/βOHProg 20α/β-Hydroxyprogesterone 17α,20α/βdiOHProg 20α/βdihydroxyprogesterone ADT Androgen deprivation therapy ANOVA Analysis of variance AR Androgen Receptor AKR Aldo-Keto Reductase ATCC American Type Culture Collection CAM Cell Adhesion Molecule CYP Cytochrome P450 CBR1 Carbonyl reductase 1 CRPC Castration resistant prostate cancer Ct-value Cycle threshold-value DHRS7 (B/C) Dehydrogenase/Reductase Short Chain Dehydrogenase Family Member 7 (B/C) DHEA Dehydroepiandrosterone DHP Dehydroprogesterone DHT 5α-Dihydrotestosterone DMEM Dulbecco's Modified Eagle's Medium DMSO Dimethyl Sulfoxide DTT Dithiothreitol E1 Estrone E2 Estradiol ECM Extracellular Membrane EDTA Ethylenediaminetetraacetic acid EMT Epithelial-mesenchymal transition ER Endoplasmic Reticulum ERα/β Estrogen Receptor α/β FBS Fetal Bovine Serum 3 FDR False discovery rate FGF Fibroblast growth factor HEPES 4-(2-Hydroxyethyl)-1-Piperazineethanesulfonic Acid HMDB Human Metabolome Database HPLC High Performance Liquid Chromatography HSD Hydroxysteroid Dehydrogenase IC50 Half-Maximal Inhibitory Concentration LNCaP Lymph node carcinoma of the prostate mRNA Messenger Ribonucleic Acid n.d.
    [Show full text]
  • Origins and Functional Impact of Copy Number Variation in the Human Genome
    doi:10.1038/nature08516 ARTICLES Origins and functional impact of copy number variation in the human genome Donald F. Conrad1*, Dalila Pinto2*, Richard Redon1,3, Lars Feuk2,4, Omer Gokcumen5, Yujun Zhang1, Jan Aerts1, T. Daniel Andrews1, Chris Barnes1, Peter Campbell1, Tomas Fitzgerald1, Min Hu1, Chun Hwa Ihm5, Kati Kristiansson1, Daniel G. MacArthur1, Jeffrey R. MacDonald2, Ifejinelo Onyiah1, Andy Wing Chun Pang2, Sam Robson1, Kathy Stirrups1, Armand Valsesia1, Klaudia Walter1, John Wei2, Wellcome Trust Case Control Consortium{, Chris Tyler-Smith1, Nigel P. Carter1, Charles Lee5, Stephen W. Scherer2,6 & Matthew E. Hurles1 Structural variations of DNA greater than 1 kilobase in size account for most bases that vary among human genomes, but are still relatively under-ascertained. Here we use tiling oligonucleotide microarrays, comprising 42 million probes, to generate a comprehensive map of 11,700 copy number variations (CNVs) greater than 443 base pairs, of which most (8,599) have been validated independently. For 4,978 of these CNVs, we generated reference genotypes from 450 individuals of European, African or East Asian ancestry. The predominant mutational mechanisms differ among CNV size classes. Retrotransposition has duplicated and inserted some coding and non-coding DNA segments randomly around the genome. Furthermore, by correlation with known trait-associated single nucleotide polymorphisms (SNPs), we identified 30 loci with CNVs that are candidates for influencing disease susceptibility. Despite this, having assessed the completeness of our map and the patterns of linkage disequilibrium between CNVs and SNPs, we conclude that, for complex traits, the heritability void left by genome-wide association studies will not be accounted for by common CNVs.
    [Show full text]
  • Supplementary Materials
    Supplementary Materials Figure S1. Bioinformatics evaluation of dystrophin isoform Dp427 and its central position in the molecular pathogenesis of X-linked muscular dystrophy. In order to generate a protein interaction map with known and predicted protein associations that include direct physical and indirect functional protein linkages, the bioinformatics STRING database [1,2] was used to analyse mass spectrometrically-identified proteins with a changed abundance in mdx-4cv skeletal muscles (Tables 1 and 2). S2 Figure S2. Focus of the bioinformatics evaluation of dystrophin isoform Dp427 and its central position in the molecular pathogenesis of X-linked muscular dystrophy. Shown is the middle part of the interaction map of altered muscle-associated proteins from mdx-4cv hind limb muscles, focusing on the central position of the dystrophin protein Dp427 (marked in yellow). In order to generate a protein interaction map with known and predicted protein associations that include direct physical and indirect functional protein linkages, the bioinformatics STRING database [1,2] was used to analyse mass spectrometrically-identified proteins with a changed abundance in mdx-4cv skeletal muscles (Tables 1 and 2). S3 Table S1. List of identified proteins that exhibit a significantly altered concentration in crude mdx-4cv hind limb muscle preparations as revealed by label-free LC-MS/MS analysis. This table contains the statistical q-values of the proteins listed in Tables 1 and 2. Accession Peptide Max Fold Highest Mean Description q Value Number
    [Show full text]